Birchview Capital, LP Portfolio Holdings

Birchview Capital, LP

  • $117 Million
  • Q4 2024

Birchview Capital, LP has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $117 Million distributed in 68 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bristol Myers Squibb CO with a value of $38.8M, Biodesix Inc with a value of $8.37M, Acadia Pharmaceuticals Inc with a value of $6.21M, Prothena Corp Public LTD CO with a value of $4.22M, and Neurocrine Biosciences Inc with a value of $4.13M.

Examining the 13F form we can see an increase of $8.74M in the current position value, from $108M to 117M.

Birchview Capital, LP is based out at Burlington, VT

Below you can find more details about Birchview Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $117 Million
Healthcare: $112 Million
Energy: $3.71 Million
ETFs: $1.63 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 68
  • Current Value $117 Million
  • Prior Value $108 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 10 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email